Screener / SEC EDGAR /CIK 0001811414 /10-K filed Feb 25, 2026, compared with Feb 26, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Technology · Miscellaneous Electrical Machinery, Equipment & Supplies

QuantumScape Corp QS

Compare with peers Embed
What it said it expected, against what it reported

1 target with a reported result

Releases of the last 3 years
Above the range 0 above the last range given
Within the range 1 of 1 range targets
Below the range 0 below the last range given

The numbers QS said it expected, in its earnings releases, next to what it then reported for the same period.

Target by target

Each target, with the sentence it came from · release and 10-Q or 10-K

The last range givenReported, abovewithin or keptbelow or missed
TargetWhat the company saidReportedResult
EBITDA (company-defined)
Fiscal 2026
Given $250.00M to $275.00M release Feb 11, 2026
Kept $250.00M to $275.00M release Apr 22, 2026
Kept $250.00M to $275.00M release Jul 22, 2026
Kept $250.00M to $275.00M release Oct 21, 2026
– No standard number
The company's words
For 2026, we expect full-year Adjusted EBITDA loss to be between $250M and $275M as we work toward our goals while continuing to drive operational efficiency across the company. release Feb 11, 2026
For full-year 2026, we reiterate our Adjusted EBITDA loss guidance of between $250M and $275M. A table reconciling GAAP net loss and Adjusted EBITDA is available in the financial statement at the end of this shareholder letter. release Apr 22, 2026
For full-year 2026, we reiterate our Adjusted EBITDA loss guidance of between $250M and $275M. A table reconciling GAAP net loss and Adjusted EBITDA is available in the financial statement at the end of this shareholder letter. release Jul 22, 2026
For full-year 2026, we reiterate our Adjusted EBITDA loss guidance of between $250M and $275M. A table reconciling GAAP net loss and Adjusted EBITDA is available in the financial statement at the end of this shareholder letter. release Oct 21, 2026
Capital expenditures
Fiscal 2026
Given $40.00M to $60.00M release Feb 11, 2026
– Not reported yet
The company's words
For 2026, we expect full-year capex to be between $40M and $60M. release Feb 11, 2026
EBITDA (company-defined)
Fiscal 2025 (ended Dec 31, 2025)
Given $250.00M to $280.00M release Feb 12, 2025
Kept $250.00M to $280.00M release Apr 23, 2025
Lowered $250.00M to $270.00M release Jul 23, 2025
– No standard number
The company's words
For 2025, we forecast capex of between $45M and $75M and Adjusted EBITDA loss to be between $250M and $280M. This reduction in overall spend from 2024 levels further aligns our workforce and our operational focus with our capital-light business model, supporting 2025 goals including shipping initial volumes of QSE-5 B1 cells for the demonstration phase of the launch program with our prospective customer. release Feb 12, 2025
We reiterate our full-year guidance for Adjusted EBITDA loss to be between $250M and $280M. release Apr 23, 2025
We narrow the range of our full-year guidance for Adjusted EBITDA loss to $250M - $270M.We ended Q2 with $797.5M in liquidity and extend our guidance for cash runway into 2029, a six-month improvement over our previous guidance. release Jul 23, 2025
EBITDA (company-defined)
Fiscal 2024 (ended Dec 31, 2024)
Given $250.00M to $300.00M release Jul 24, 2024
Raised $280.00M to $300.00M release Oct 23, 2024
– No standard number
The company's words
We maintain our full-year 2024 guidance for Adjusted EBITDA loss to be between $250M and $300M and expect to be on the lower end of our capital expenditure guidance range of $70M to $120M. release Jul 24, 2024
We now tighten our full-year forecast for Adjusted EBITDA loss to be between $280M and $300M—within original guidance but at the higher end of the original range, primarily due to higher legal fees and settlement accruals in 2024 that we do not expect to reoccur in 2025. release Oct 23, 2024
Capital expenditures
Fiscal 2024 (ended Dec 31, 2024)
Given $60.00M to $75.00M release Oct 23, 2024
$62.13M
10-K filed 2025-02-26
Within the range
The company's words
We are lowering our 2024 forecast for capital expenditures to be between $60M and $75M, driven by realized PowerCo deal- related efficiencies, non-deal related savings, and a shift in timing of certain payments originally planned for late 2024 into 2025. release Oct 23, 2024

Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (12 releases since 2024-02-14), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.

Sources

The outlook sentences of each earnings release (8-K item 2.02, exhibit 99), read without AI; results from SEC's XBRL company facts, as first reported.

Also

Earnings releases: each release in full.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/QS/export.csv") into a cell.

Next:Archive
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.